Helen Belcastro

Helen Belcastro brings over 20 years of experience in cross-functional program and project management in the medical device and biotechnology arenas to her role as Vice President, Portfolio Planning and Program Management at Alveo Technologies. Previously, she applied her program management leadership to the digital transformation of molecular diagnostics at Atonarp, helping to improve clinical outcomes and enhance the patient experience. Prior to Atonarp, Helen built her extensive experience managing complex product development projects at all stages from concept through product release through her work at companies including ViewRay, Inc., VytronUS, Intuitive Surgical, Novartis Vaccines and Diagnostics, and Boston Scientific.